Artelo Biosciences Reports 2nd Quarter Fiscal 2021 Money Final results and Delivers Business Update
Not long ago Commenced Affected person Enrollment in Period 1/2 CAReS Study of Art27.13 in the British islesNoted Favourable Pre-Medical...
Biosciences
Interpace Biosciences Announces Full Year and Fourth Quarter 2020 Financial and Business Results
2020 Full Year Net Revenue of $32.4 Million Up 34% vs Prior Year; Fourth Quarter Net Revenue of $9.6M Million...
Brii Biosciences Closes US$155 Million Collection C Financing | Organization & Finance
DURHAM, N.C. & BEIJING--(Organization WIRE)--Mar 23, 2021--Brii Biosciences (“Brii Bio”), a multi-countrywide business acquiring ground breaking therapies for diseases with...
IDEAYA Biosciences, Inc. Reports Fourth Quarter 2020 Financial Results and Provides Business Update
- Initiated Phase 1 clinical trial for IDE397, a potential best-in-class MAT2A inhibitor for patients having tumors with MTAP-deletion- Planning...
Selecta Biosciences Reports Recent Business Highlights and Fourth Quarter and Full Year 2020 Financial Results
- First-in-human dose-escalation study to evaluate ability of ImmTOR™ to mitigate immunogenicity of AAV capsid initiated with initial data expected...
Caladrius Biosciences Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
Company demonstrates resilience despite COVID-19 challenges: Financial situation secure and development programs progressingConference call begins today at 4:30 p.m. (ET)BASKING...
Vedanta Biosciences Appoints Mark Mullikin as Main Financial Officer | Enterprise & Finance
CAMBRIDGE, Mass.--(Company WIRE)--Feb 8, 2021--Vedanta Biosciences, a foremost scientific-phase corporation creating a new group of therapies for immune-mediated health conditions...
IFF to Total Merger With DuPont’s Nutrition & Biosciences Small business
NEW YORK--(Enterprise WIRE)--IFF (NYSE: IFF) to total the beforehand declared merger of IFF and DuPont’s Nourishment & Biosciences (“N&B”) business...
